Detalhe da pesquisa
1.
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques.
Immunity
; 56(7): 1649-1663.e5, 2023 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37236188
2.
Assessment of Mobility Trajectories Using Wearable Inertial Sensors During Autologous Hematopoietic Cell Transplant.
Arch Phys Med Rehabil
; 2024 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38354878
3.
Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates.
Cytotherapy
; 25(4): 423-431, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36690537
4.
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?
Support Care Cancer
; 30(3): 1903-1906, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34741653
5.
Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.
Xenotransplantation
; 27(4): e12578, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31930750
6.
Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors.
Cytotherapy
; 21(7): 725-737, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31085121
7.
Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
Am J Hematol
; 94(8): 902-912, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31124175
8.
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population.
Biol Blood Marrow Transplant
; 21(1): 89-96, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25445641
9.
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.
Biol Blood Marrow Transplant
; 21(4): 720-8, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25555450
10.
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
Biol Blood Marrow Transplant
; 21(6): 1029-36, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25759146
11.
12.
Frailty and Preoperative Palliative Care in Surgical Oncology.
Curr Probl Cancer
; 47(5): 101021, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37865539
13.
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
Blood Adv
; 7(9): 1899-1909, 2023 05 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36441905
14.
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial.
Lancet Haematol
; 9(1): e14-e25, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34971577
15.
Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma.
Transplant Cell Ther
; 28(8): 487.e1-487.e7, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35609865
16.
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Transplant Cell Ther
; 27(8): 662.e1-662.e9, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33901720
17.
Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients.
Biol Blood Marrow Transplant
; 16(2): 192-8, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19781656
18.
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease.
Blood Adv
; 4(8): 1656-1669, 2020 04 28.
Artigo
Inglês
| MEDLINE | ID: mdl-32324888
19.
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.
Hematol Oncol Stem Cell Ther
; 12(2): 105-109, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30836091
20.
A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT).
Bone Marrow Transplant
; 53(8): 1010-1018, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29459665